Humanigen is not currently accepting enquiries regarding lenzilumab for emergency use.

​

Humanigen's Phase III study in COVID-19 is now enrolling. Click here for more information.

​

See also:

​

Mayo Clinic Study of Humanigen’s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients (more information)

​

Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients (more information)